Method of Treating Chronic Myeloid Leukemia Using Pegylated Interferon and Tyrosine Kinase Inhibitor
Described herein is a method of treating chronic myeloid leukemia in a subject including administering to a subject in need thereof a pegylated interferon-a and a BCR-ABL tyrosine kinase inhibitor simultaneously or sequentially.
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
06.04.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!